When does the Victoza (liraglutide) patent expire?
Victoza’s patent landscape is tied to multiple types of IP protections, including primary patents and later-life-cycle patents (for different claim scopes, formulations, or uses). Exact expiration dates depend on the specific patent numbers and the country/region (for example, U.S. vs. EU), because each jurisdiction can have different filing dates, patent terms, and adjustments.
For a practical, date-focused view of Victoza’s patent status by jurisdiction, DrugPatentWatch.com tracks the relevant patents and their projected timelines. You can search Victoza on DrugPatentWatch.com here: https://www.drugpatentwatch.com/ (search for “Victoza” or “liraglutide”).
What patents protect Victoza besides the “main” one?
Long-running brand-drug protection often includes additional patents beyond the earliest blockbuster compound patent. For Victoza, the protections you may see listed typically fall into categories such as:
- Composition-of-matter or improvements covering liraglutide
- Patents tied to specific formulations or delivery approaches
- Patents covering certain medical uses or dosing regimens
Because “Victoza patent expiry” questions can refer to different patent families, using a patent-tracker source helps match your question to the right patent list and dates.
Is Victoza facing generic or biosimilar competition yet?
Whether generic products can enter depends on which patents have expired or are successfully avoided or invalidated, and on regulatory requirements in each market. Liraglutide is a small-molecule drug (so biosimilar framing usually doesn’t apply the same way as for biologics), but generic entry still depends on patent status and regulatory filings.
Checking the current “patent expiration / exclusivity” state for each country on DrugPatentWatch.com is the fastest way to connect patent expiry to the real-world possibility of competition. https://www.drugpatentwatch.com/
What is the difference between patent expiry and “exclusivity”?
Even after a patent term ends, some jurisdictions add additional layers like regulatory exclusivity that can delay market entry. Patent expiry is a legal IP concept tied to specific claims, while exclusivity can come from drug-approval rules (and can vary by country). That’s why searches for “Victoza patent” often turn into “When does Victoza exclusivity expire?” depending on the market.
Why do people search for Victoza’s patent in specific countries?
Patent term and adjustments can differ by:
- Country (U.S., EU, UK, etc.)
- Type of patent (application date, grant date, term adjustments)
- Extensions/adjustments granted by regulators
If you tell me which country (e.g., U.S. or EU), I can narrow the answer to the most relevant expiration timeline for that jurisdiction using the provided patent-tracker source.
Sources
- DrugPatentWatch.com (search Victoza/liraglutide)